Global Blood Stock Price, News & Analysis
Company Description
Global Blood (NASDAQ: GBT) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $4.6B.
GBT stock has gained 162.2% over the past year.
This page provides a comprehensive overview of GBT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Global Blood (GBT) stock. Over the past 12 months, the stock has gained 162.2%. At a market capitalization of $4.6B, GBT is classified as a mid-cap stock with approximately 67.5M shares outstanding.
Latest News
Global Blood has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include conferences, acquisition, earnings. View all GBT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GBT Company Profile & Sector Positioning
Global Blood (GBT) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing GBT often look at related companies in the same sector, including Ptc Therapeutics (PTCT), Crispr Therapeut (CRSP), Jyong Biotech Ltd. (MENS), ARCELLX INC (ACLX), and Vaxcyte, Inc. (PCVX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GBT's relative position within its industry.